ABBV vs UNH: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+28.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
UNH |
| Current Price |
$261.70 |
$375.21 |
| Fair Value Estimate |
$259.04 |
$481.06 |
| Upside to Fair Value |
-1.0%
|
+28.2%
|
| Market Cap |
$462.4B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
15.0x
|
| Price / Sales |
7.2x
|
0.8x
|
| Price / FCF |
23.6x
|
14.4x
|
| Revenue Growth YoY |
+10.2%
|
+0.4%
|
| Gross Margin |
71.5%
|
22.5%
|
| Operating Margin |
29.3%
|
4.8%
|
| Return on Equity |
-136.5%
|
14.6%
|
| Dividend Yield |
2.61% |
2.41% |
| FCF Yield |
4.25%
|
6.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
ABBV |
UNH |
| Zone Low |
$194.28 |
$360.80 |
| Zone High |
$220.18 |
$408.90 |
| In Buy Zone? |
No
|
Yes
|